Sano Y, Tanaka S, Kudo SE, Saito S, Matsuda T, Wada Y, Fujii T, Ikematsu H, Uraoka T, Kobayashi N, Nakamura H, Hotta K, Horimatsu T, Sakamoto N, Fu KI, Tsuruta O, Kawano H, Kashida H, Takeuchi Y, Machida H, Kusaka T, Yoshida N, Hirata I, Terai T, Yamano HO, Kaneko K, Nakajima T, Sakamoto T, Yamaguchi Y, Tamai N, Nakano N, Hayashi N, Oka S, Iwatate M, Ishikawa H, Murakami Y, Yoshida S, Saito Y (2016) Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team

all the available evidence-based clinical guidelines are set upon a dichotomic diagnostic approach (all melanocytic tumors are either nevi or melanomas) and upon a unifying concept of melanoma (all melanocytic malignancies have the same biological behavior which can be predicted on the basis of a universally applicable set of histopathological parameters) ( In 2014, the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) schema was proposed in an effort to reduce uncertainty and offer guidelines, mostly for melanocytic tumors different from melanoma (the classical melanocytic malignancy with its own evidence-based guidelines) (74): notably, the original schema excluded some melanocytic tumors (pigmented spindle cell
During the dose-escalation phase (usually lasting 16 to 20 weeks), weekly losses tend to be smaller because you're on lower doses
The interrelationships among these factors further accelerate aging, leading to a chronic disease state
Follow-up appointments will be scheduled to monitor your progress and adjust the dosage if needed, based on how your body responds to the treatment